bluebird bio, Inc. announced that on January 31, 2022, Jessica Whitten, chief accounting officer and principal accounting officer of the Company provided notice of her resignation from bluebird effective upon the Company's filing of its annual report on Form 10-K covering the period ended December 31, 2021. Gina Consylman, bluebird's chief financial officer and principal financial officer will serve as interim principal accounting officer until Ms. Whitten's replacement is hired.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.905 USD | -1.04% | +0.18% | -34.42% |
29/05 | Bluebird bio, Inc. Announces Executive Changes, Effective from June 10, 2024 | CI |
29/05 | Bluebird bio, Inc. Announces Chief Financial Officer Changes, Effective June 10, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.42% | 174M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Bluebird bio, Inc. Announces Resignation of Jessica Whitten as Chief Accounting Officer and Principal Accounting Officer